Recombinant, Bivalent, Norovirus Vaccine Study
Clinical trial NCT05508178 · COMPLETED
Trial details
- NCT number
- NCT05508178
- Sponsor
- Icon Genetics GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-17
- Primary completion
- 2021-10-26
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.